InsiderTrades.com logo
Ever heard of this 8-day bitcoin profit window?
From DTI   |   Ad
Did you know Bitcoin almost always soars higher during an 8-Day Profit Window? Most people have no clue… But for over a year now, some of our top students have had the chance to cash in with some incredible gains during this 8-day window.
It’s coming up quick.

PTPI Insider Trading

Insider Ownership Percentage: 12.25%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

Petros Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Petros Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Petros Pharmaceuticals Share Price & Price History

Current Price: $0.25
Price Change: +0.30 (1.20%)
As of 11/21/2024 01:00 AM ET

This chart shows the closing price history over time for PTPI up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Buffett Dumps $982 Million in BofA Stock—What Does He Know?
From Genesis Gold Group   |   Ad
Buffett's been eerily quiet about his reasons, but his actions speak volumes. When someone with his track record starts pulling out of the market, it's time to pay attention.
Get your FREE, no-obligation Wealth Protection Guide now

Petros Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/29/2021John D. ShulmanDirectorBuy50,000$30.00$1,500,000.00View SEC Filing Icon  
See Full Table
I've got news for you…
From DTI   |   Ad
Today, I’m doing something I thought I’d never do… Especially since I’m not normally a “swing for the fences” type of trader. But I’ve been quietly testing a new type of trade for a while now… And the returns are too good not to share with you. Take a look… I can’t guarantee results or against losses, but if you want to discover how I’ll target the triple return before the end of the week
watch this FREE briefing with me and expert trader Graham Lindman

SEC Filings (Institutional Ownership Changes) for Petros Pharmaceuticals (NASDAQ:PTPI)

12.34% of Petros Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at PTPI by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Petros Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/2/2023Bank of Montreal Can10,000$27K0.0%N/A0.478%Search for SEC Filing on Google Icon
1/27/2022Emfo LLC10,000$33K0.0%-64.3%0.048%Search for SEC Filing on Google Icon
11/12/2021NorthRock Partners LLC115,295$0.43M0.0%-47.4%1.173%Search for SEC Filing on Google Icon
9/17/2021Virtu Financial LLC14,364$45K0.0%N/A0.146%Search for SEC Filing on Google Icon
8/16/2021Shay Capital LLC238,764$0.75M0.1%-7.0%2.437%Search for SEC Filing on Google Icon
8/13/2021Renaissance Technologies LLC54,887$0.17M0.0%-70.4%0.560%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC23,725$74K0.0%+67.3%0.242%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.107,500$0.34M0.0%+21.2%1.097%Search for SEC Filing on Google Icon
8/12/2021NorthRock Partners LLC219,188$0.69M0.1%-35.1%2.237%Search for SEC Filing on Google Icon
8/10/2021CM Management LLC100,000$0.31M0.2%+122.2%1.021%Search for SEC Filing on Google Icon
8/5/2021Platform Technology Partners44,000$0.14M0.1%N/A0.449%Search for SEC Filing on Google Icon
5/21/2021Citadel Advisors LLC35,492$0.13M0.0%N/A0.362%Search for SEC Filing on Google Icon
5/18/2021Citadel Advisors LLC35,492$0.13M0.0%N/A0.363%Search for SEC Filing on Google Icon
5/13/2021Renaissance Technologies LLC185,545$0.69M0.0%+29.5%1.900%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC14,180$52K0.0%N/A0.145%Search for SEC Filing on Google Icon
5/11/2021NorthRock Partners LLC337,531$1.26M0.1%-12.3%3.455%Search for SEC Filing on Google Icon
5/7/2021BlackRock Inc.18,277$68K0.0%+35.1%0.187%Search for SEC Filing on Google Icon
4/12/2021FNY Investment Advisers LLC20,000$73K0.0%N/A0.205%Search for SEC Filing on Google Icon
3/4/2021Neville Rodie & Shaw Inc.21,875$96K0.0%N/A0.224%Search for SEC Filing on Google Icon
2/16/2021One68 Global Capital LLC24,883$0.11M0.2%N/A0.255%Search for SEC Filing on Google Icon
2/11/2021Cannell Peter B & Co. Inc.25,484$0.11M0.0%N/A0.261%Search for SEC Filing on Google Icon
2/10/2021Renaissance Technologies LLC143,247$0.63M0.0%N/A1.466%Search for SEC Filing on Google Icon
2/8/2021NorthRock Partners LLC385,031$1.69M0.2%N/A3.942%Search for SEC Filing on Google Icon
2/5/2021BlackRock Inc.13,531$59K0.0%N/A0.284%Search for SEC Filing on Google Icon
2/5/2021CM Management LLC45,000$0.20M0.2%N/A0.946%Search for SEC Filing on Google Icon
1/25/2021Acorn Financial Advisory Services Inc. ADV62,700$0.28M0.1%N/A1.318%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Petros Pharmaceuticals logo
Petros Pharmaceuticals, Inc., a pharmaceutical company, focuses on men's health therapeutics in the United States and internationally. It operates through two segments, Prescription Medications and Medical Devices. The company engages in the commercialization and development of Stendra, an PDE-5 inhibitor prescription medication for the treatment of erectile dysfunction (ED). It also develops and commercializes H100, a novel and patented topical formulation candidate for the treatment of acute Peyronie's disease. The company offers men's health products, including vacuum erection devices, penile injections, PreBoost, VenoSeal, and urinary tract infection tests for the treatment of erectile dysfunction. Petros Pharmaceuticals, Inc. is based in New York, New York.
Read More on Petros Pharmaceuticals

Today's Range

Now: $0.25
Low: $0.23
High: $0.27

50 Day Range

MA: $0.34
Low: $0.25
High: $0.42

52 Week Range

Now: $0.25
Low: $0.22
High: $2.27

Volume

226,844 shs

Average Volume

519,343 shs

Market Capitalization

$2.50 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.11
Ever heard of this 8-day bitcoin profit window?
From DTI   |   Ad
Did you know Bitcoin almost always soars higher during an 8-Day Profit Window? Most people have no clue… But for over a year now, some of our top students have had the chance to cash in with some incredible gains during this 8-day window.
It’s coming up quick.